HORIZON-HLTH-2025-01-DISEASE-01

With extensive experience in international research projects, CCMIJU and its scientific units offer proven expertise in the development of novel medical devices, bioprinting techniques and biomaterials, as well as advanced capabilities in cell culture, characterization, and both in vitro and in vivo testing.

CCMIJU is interested in joining consortia and can contribute specifically to activities aligned with the following scope:
“Use of innovative in silico, in vitro, or in vivo models to support the pre-clinical selection of phages for clinical trial application.”

Our structure uniquely combines basic research laboratories, and experienced surgical research teams. This integrated approach allows us to design and implement comprehensive solutions to complex biomedical challenges across a wide range of fields.